Login / Signup

Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles.

Marc D HeinPrerna AroraPavel Marichal-GallardoMichael WinklerYvonne GenzelStefan PöhlmannKlaus SchughartSascha Young KupkeUdo Reichl
Published in: BMC biology (2021)
In summary, experiments not only demonstrated that purely clonal influenza virus DIP preparations can be obtained with high titers from animal cell cultures but confirmed the potential of cell culture-derived DIPs as an antiviral agent.
Keyphrases
  • single cell
  • cell therapy
  • human health
  • stem cells
  • risk assessment
  • bone marrow
  • mesenchymal stem cells
  • climate change